Healing cooling systems in medicine: technotrans intensifies its activities in the healthcare target market

  • New product for cooling in cancer therapies in clinical trials

  • Application of cooling for diseases of developing civilization and sport

  • Focus on energy efficiency and climate friendliness

technotrans SE expands its solution competence in the targeted healthcare and analytics market. In line with its “Future Ready 2025” strategy, the thermal management specialist is currently developing several new cooling solutions for medical applications. The highlight among the new products is BrainCool AB’s Cooral® cooling system, which can be used for patients undergoing chemotherapy. Oral cooling devices are effective against serious side effects of cancer treatment, such as open sores or peeling of the oral mucosa. After the completion of clinical trials, the market launch of the solution is planned for this year. In addition, technotrans is developing a cooling armband for the treatment of civilization diseases and sports injuries.

“The healing effect of cold, applied for example to bruises, has long been proven in the medical context. There are many ways to use cooling for this purpose. In view of the increasing number of patients suffering from diseases of civilization or of sports injuries, we are convinced that the demand for thermal solutions will increase significantly”, says Jan Kröger, Managing Director of termotek GmbH (future: technotrans systems GmbH). Potential areas of application for cooling solutions include injuries joints and tissues, pain treatments, rheumatoid and connective tissue diseases as well as muscle relaxation or treatment of paralysis.

Currently, several technotrans solutions for medical applications are under development and testing. The highlight among the new products is the Cooral cooling system® by BrainCool AB: technotrans has been working with this European medical device manufacturer for several years to develop cooling accessories for oral use for patients undergoing cancer treatment. Cancer is often treated with chemotherapy. The drugs used for this treatment can have significant side effects, such as open sores or peeling of the lining of the mouth (oral mucositis). These side effects cause considerable pain to patients and can lead to inflammation or even life-threatening sepsis. Cooling decreases blood circulation and metabolism in the affected areas so that the active ingredients of the drugs do not penetrate the mucous membranes of the mouth. This helps prevent or at least reduce oral mucositis. At present, the device is in the final phase of the project. After a successful clinical trial, market launch is planned for later this year.

Flexible areas of application and energy-efficient operation
Another innovative product is the cooling armband for the treatment of civilization diseases and sports injuries such as bruises or rheumatoid conditions. The system consists of a cart with a hose and a gel cuff to cool the affected skin area. Thanks to an intelligent 3D chip, the cooling power is precisely matched to the patient. In addition, the device can also be used to warm the affected areas. The system requires very little maintenance and is characterized by its compact size, low noise level and excellent reliability. technotrans uses sustainable natural refrigerants such as propane and isobutane for these devices. The cooling cuff system will undergo clinical testing in 2022.

As a specialist in thermal management solutions, technotrans relies on its long experience in the medical engineering sector for the development of innovative solutions. The company also develops customized laser cooling solutions for diagnostic and therapeutic purposes. In line with its “Future Ready 2025” group strategy, which identifies the healthcare and analytics sector as an important target market, technotrans will expand its activities in this area. Michael Finger, spokesman for the board of directors of technotrans SE, explains what the company envisions for this market: “Our goal is to develop compact, safe and technically sophisticated cooling and temperature control solutions for a wide capacity range. The group will place particular emphasis on a high level of energy efficiency and respect for the environment of the appliances. “These characteristics are particularly important for systems intended for thermal applications in the medical sector. That is why durability and the lowest possible CO2 the imprint plays a decisive role in product development”, adds Michael Finger.

Sara H. Byrd